Supplementary Tables from The Glutaminase Inhibitor CB-839 (Telaglenastat) Enhances the Antimelanoma Activity of T-Cell–Mediated Immunotherapies

Authors :: Y.N. Vashisht Gopal
Weiyi Peng
Jason Roszik
Yared Hailemichael
Jennifer L. McQuade
Andrew L. Mackinnon
Philip L. Lorenzi
Lin Tan
Barbara Knighton
Catherine K. Luo
Grant M. Fischer
Courtney W. Hudgens
Hannah R. Hodges
Leila J. Williams
Snigdha Pramanik
Sruthy Varghese
Publication Year :: 2023
Publisher :: American Association for Cancer Research (AACR), 2023.
Abstract: Supplementary tables

Tools